Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors

par Xue-lin Zou, Wei-yong Chen, Guang-yan Zhang, Hua Ke, Qiu-hong Yang, Xiao-bo Li
Publié 2021

Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI) Versus Non-ICI Era: A Population-Based Study

par Mohammed Safi, Mahmoud Al-Azab, Chenxing Jin, Dario Trapani, Salem Baldi, Salah Adlat, Aman Wang, Bashir Ahmad, Hamza Al-madani, Xiu Shan, Jiwei Liu
Publié 2021

Identification and Validation of Immune-Related Gene for Predicting Prognosis and Therapeutic Response in Ovarian Cancer

par Zhao-Cong Zhang, Jun-Nan Guo, Ning Zhang, Zhi-Qiang Wang, Ge Lou, Bin-Bin Cui, Chang Yang
Publié 2021

Novel Tumor-Specific Antigens for Immunotherapy Identified From Multi-omics Profiling in Thymic Carcinomas

par Wentao Fang, Chia-Hsin Wu, Qiang-Ling Sun, Qiang-Ling Sun, Zhi-Tao Gu, Lei Zhu, Teng Mao, Xue-Fei Zhang, Ning Xu, Tzu-Pin Lu, Tzu-Pin Lu, Mong-Hsun Tsai, Mong-Hsun Tsai, Li-Han Chen, Liang-Chuan Lai, Liang-Chuan Lai, Eric Y. Chuang, Eric Y. Chuang, Eric Y. Chuang, Eric Y. Chuang
Publié 2021

Immunotherapy in the First-Line Treatment of NSCLC: Current Status and Future Directions in China

par Anwen Xiong, Jiali Wang, Caicun Zhou
Publié 2021

Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside

par Linda Wu, Linda Wu, Linda Wu, Linda Wu, Venessa H. M. Tsang, Venessa H. M. Tsang, Sarah C. Sasson, Sarah C. Sasson, Sarah C. Sasson, Alexander M. Menzies, Alexander M. Menzies, Alexander M. Menzies, Matteo S. Carlino, Matteo S. Carlino, Matteo S. Carlino, David A. Brown, David A. Brown, David A. Brown, David A. Brown, Roderick Clifton-Bligh, Roderick Clifton-Bligh, Jenny E. Gunton, Jenny E. Gunton, Jenny E. Gunton
Publié 2021

Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials

par Yunhai Li, Lei Xing, Fan Li, Hong Liu, Lu Gan, Dejuan Yang, Mengxue Wang, Xuedong Yin, Hongyuan Li, Guosheng Ren, Guosheng Ren
Publié 2021

Favorable Immune Microenvironment in Patients with EGFR and MAPK Co-Mutations

par Yang W, Chen N, Li L, Chen X, Liu X, Zhang Y, Cui J
Publié 2020

Role of Immune Checkpoint Inhibitor Therapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer

par Nathaniel Wiest, Umair Majeed, Karan Seegobin, Yujie Zhao, Yanyan Lou, Rami Manochakian
Publié 2021

Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma

par Di Wang, Kai Sun, Tianqi Wang, Dongxu Zhang, Fengze Sun, Yuanshan Cui, Hongwei Zhao, Jitao Wu
Publié 2021